CJC-1295 with DAC vs without DAC: Tracking Guide
CJC-1295 with DAC vs CJC-1295 without DAC
CJC-1295 comes in two variants with significantly different half-lives affecting dosing frequency. Understanding which variant you're tracking is essential for accurate scheduling in Dosed.
Important Disclaimer
CJC-1295 (both variants) is a research compound NOT approved by the FDA for human use. Dosed tracking is for research and educational purposes only. This is not medical advice. Consult qualified healthcare professionals.
Comparison Table
Key Differences
- →Dramatically different half-lives: 6-8 days (DAC) vs ~30 minutes (no DAC)
- →Dosing frequency differs: weekly vs multiple times daily
- →DAC variant has extended duration from Drug Affinity Complex
- →Non-DAC requires more frequent tracking and reminders
- →Both require reconstitution - same calculator in Dosed
Tracking Considerations
- •Select the correct variant in Dosed - scheduling differs significantly
- •With DAC: Use weekly scheduling similar to weekly GLP-1s
- •Without DAC: Use multiple daily reminders feature
- •Reconstitution tracking works the same for both variants
- •Research compound - for educational tracking purposes only
Dosed App Features
- ✓Variant selection for proper scheduling configuration
- ✓Weekly scheduling for DAC variant
- ✓Multi-dose daily scheduling for non-DAC variant
- ✓Reconstitution calculator for both variants
- ✓Research protocol logging
Quick Reference
- 💡DAC = Drug Affinity Complex, extends half-life significantly
- 💡Non-DAC may also be called "mod GRF 1-29"
- 💡The ~200x difference in half-life determines scheduling approach
- 💡Both are research compounds - not FDA approved
Track Your Protocol
Set up reminders, track your doses, and maintain your protocol history with Dosed.
Download DosedFAQs
Common questions about this comparison
The DAC (Drug Affinity Complex) version has a half-life of 6-8 days (PMID: 16352683), allowing weekly dosing. Without DAC, the half-life is ~30 minutes (PMID: 17018654), requiring multiple daily doses in research protocols.
Check your research compound labeling - it should specify "with DAC" or "without DAC" (sometimes labeled "mod GRF 1-29" for the non-DAC version). Configure Dosed according to your specific variant.
No, neither CJC-1295 variant is FDA approved for human use. Both are research compounds. Dosed provides tracking for research documentation purposes only.